Öffentliche Gesundheit und öffentliches Vertrauen – Der Ruf von Nordic Pharma

Time: Thursday 26 June at 13:00–13:55

Das Vertrauen in die Pharmaindustrie ist für die öffentliche Gesundheit von entscheidender Bedeutung – doch Vertrauen ist zerbrechlich. Was prägt das Vertrauen in eine Branche, die von hohen Erwartungen und strengen Vorschriften geprägt ist? Und was geschieht, wenn das Vertrauen in die nordische Pharmaindustrie zu bröckeln beginnt?

Join us live at Almedalen or via Teams. The event will take place on a historical sailing ship! You’ll find the schooner Svanhild af Borgå docked at Österdahls Brygga in the port of Visby. Please register for the seminar below and make sure you receive a confirmation email.

The pharmaceutical industry plays a crucial role in public health, yet trust in companies remains fragile. While innovation and life-saving treatments drive progress, concerns over pricing, transparency, and corporate ethics continue to shape public perception. What builds confidence in this highly regulated sector, and what erodes it?

Reputation and Trust Analytics presents findings from a comprehensive study on trust in pharmaceutical companies across the Nordics. The analysis highlights how reputation impacts on stakeholder behaviors. How can the industry balance innovation with accountability? What role do communication, policy, and corporate responsibility play in securing trust?

Teilnehmer

Edvard Agrell, Corporate Public Affairs Manager, Bayer

Erik Kjellin, Head of Press, Lif – De Forskande Läkemedelsföretagen

Pia Steensland, Director of Policy & Public affairs, Pfizer Sverige

Tobias Lundin Gerdås, Policy and Government Affairs Partner, Roche Sweden

Sofia Rydgren Stale, President, Läkarförbundet

Andrei Sergejeff, Senior Advisor, Reputation and Trust Analytics

Peter Markström, Berater, Reputation- und Vertrauensanalyse

Andrei Sergejeff, Senior Advisor, Reputation and Trust Analytics